Longeveron to Participate in Upcoming 2022 Investor Conferences
MIAMI, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced that Company leadership will participate in three upcoming investor conferences.
A.G.P.’s Virtual Biotech Conference
The Benchmark Company 11th Annual Discovery One-on-One Investor Conference
RHK 2022 Disruptive Growth Conference
A live webcast of the presentation at the RHK 2022 Disruptive Growth Conferece can be accessed by visiting “Events & Presentations” in the Investors section of Longeveron’s website at https://investors.longeveron.com/events-and-presentations/default.aspx. A replay of the webcast will be available shortly following the conference.
About Longeveron Inc.
Source: Longeveron Inc
Press Room Open for Registered Media, Analysts, Speakers, Exhibitors - Sponsored by Parallel Communications
Scaling & Managing Real-time Communication Workloads in Kubernetes
Solutions Showcase Theatre Presentations on Expo Floor